Physician
Medical Associates of Vicksburg PLLC
Medical Associates of Vicksburg PLLC was paid $4.30M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoMEDICAL ASSOCIATES OF VICKSBURG PLLC
VICKSBURG, MS 39180
VICKSBURG, MS 39180
33aNPI1508278177assigned 05/29/2014
33bProvider typeInternal Medicine Physician
28Total paid$4.30M
24GClaims352,388
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Mississippi
Rank by total paid#4 of 139
Median peer was paid$26K
This provider vs. median165×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 79,063 | $799K | |
| 2019 | 68,431 | $821K | |
| 2020 | 63,134 | $802K | |
| 2021 | 51,965 | $767K | |
| 2022 | 45,373 | $498K | |
| 2023 | 24,476 | $353K | |
| 2024incomplete | 19,946 | $255K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 42,424 | 35,649 | $1.80M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 21% | 45,857 | 9,649 | $884K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 13,701 | 11,641 | $476K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.0% | 12,652 | 11,203 | $301K |
| 99223 | Prolong inpt eval add15 m | 4.8% | 3,253 | 2,843 | $207K |
| 99222 | Initial hospital care, per day, moderate complexity | 3.2% | 2,787 | 2,427 | $137K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 8,862 | 5,557 | $45K |
| 99490 | Ccm add 20min | <1% | 7,271 | 7,085 | $39K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,037 | 12,364 | $37K |
| 99307 | <1% | 2,875 | 2,543 | $33K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,488 | 10,225 | $33K |
| 80061 | Lipid panel | <1% | 7,950 | 7,210 | $31K |
80 more codes
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 941 | $28K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 991 | $27K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,658 | $20K |
| 80076 | <1% | 7,550 | $20K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 639 | $19K |
| 94681 | <1% | 992 | $16K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 843 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,777 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 914 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,095 | $10K |
| 80053 | Comprehensive metabolic panel | <1% | 2,211 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 224 | $8K |
| 90682 | <1% | 352 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 328 | $7K |
| 94375 | <1% | 748 | $6K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,229 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,801 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 458 | $5K |
| J2010 | Injection, lincomycin hcl, up to 300 mg | <1% | 353 | $4K |
| 94200 | <1% | 754 | $3K | |
| 94726 | <1% | 324 | $3K | |
| 99454 | <1% | 417 | $3K | |
| 99304 | <1% | 98 | $3K | |
| 80305 | <1% | 405 | $3K | |
| 83735 | <1% | 1,000 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 219 | $2K |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 28,654 | $2K |
| 94690 | <1% | 259 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 29 | $2K |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 29,884 | $2K |
| 90686 | <1% | 168 | $2K | |
| 81001 | <1% | 1,260 | $1K | |
| G9584 | Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy | <1% | 6,366 | $1K |
| 99457 | <1% | 254 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,332 | $916.04 |
| 86769 | <1% | 77 | $893.34 | |
| 95923 | <1% | 55 | $764.90 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 49 | $701.53 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 92 | $663.36 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $623.97 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 24 | $493.24 |
| 80050 | General health panel | <1% | 15 | $371.56 |
| 99441 | <1% | 15 | $357.79 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 120 | $332.75 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 20,109 | $328.77 |
| 99406 | <1% | 84 | $283.26 | |
| 96165 | <1% | 29 | $240.00 | |
| G9583 | Patients prescribed opiates for longer than six weeks | <1% | 5,418 | $235.57 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 802 | $200.46 |
| 93922 | <1% | 12 | $193.97 | |
| 95921 | <1% | 13 | $190.89 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $185.98 |
| 73562 | <1% | 14 | $165.63 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 136 | $138.47 |
| 96164 | <1% | 29 | $120.00 | |
| 82607 | <1% | 12 | $96.50 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 61 | $95.85 |
| 90662 | <1% | 189 | $86.01 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 8,701 | $84.45 |
| 1036F | <1% | 21,808 | $83.10 | |
| 99497 | <1% | 131 | $70.56 | |
| 95943 | <1% | 26 | $64.44 | |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 64 | $60.00 |
| 1124F | <1% | 2,935 | $48.72 | |
| 85652 | <1% | 57 | $46.19 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 161 | $40.81 |
| 1123F | <1% | 1,458 | $39.16 | |
| G8399 | Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed | <1% | 1,102 | $37.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 134 | $26.69 |
| 4004F | <1% | 5,312 | $10.24 | |
| G0008 | Administration of influenza virus vaccine | <1% | 549 | $8.72 |
| 4040F | <1% | 1,589 | $6.87 | |
| 1126F | 0% | 71 | $0.00 | |
| 1125F | 0% | 248 | $0.00 | |
| 1170F | 0% | 317 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 15 | $0.00 |
| 3074F | 0% | 48 | $0.00 | |
| 1160F | 0% | 285 | $0.00 | |
| 1159F | 0% | 254 | $0.00 | |
| 3078F | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPIERCE, PAUL (LLC MEMBER)